Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal Cancer

Overview

Journal Cancer Prev Res (Phila)

Specialty Oncology

Date 2024 Jan 29

PMID 38286404

Authors

Brittney L Dickey

Ryan M Putney

Michael J Schell

Anders E Berglund

Antonio L Amelio

Jimmy J Caudell

Christine H Chung

Anna R Giuliano

Affiliations

Soon will be listed here.

Abstract

Prevention Relevance: This study identified biomarkers using genome-wide methylation to create a panel capable of discerning early oropharyngeal cancer (OPC) from those without OPC. Such a biomarker panel would be an effective tool to detect OPC early and prevent complications of treatment associated with later diagnosis.

References

Ferris R, Flamand Y, Weinstein G, Li S, Quon H, Mehra R . Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol. 2021; 40(2):138-149. PMC: 8718241. DOI: 10.1200/JCO.21.01752. View

Faraji F, Eisele D, Fakhry C . Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2017; 2(1):10-18. PMC: 5510283. DOI: 10.1002/lio2.37. View

Wu T, Giovannucci E, Welge J, Mallick P, Tang W, Ho S . Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer. 2011; 105(1):65-73. PMC: 3137397. DOI: 10.1038/bjc.2011.143. View

Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32):4294-301. PMC: 3221528. DOI: 10.1200/JCO.2011.36.4596. View

Muller H, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M . Methylation changes in faecal DNA: a marker for colorectal cancer screening?. Lancet. 2004; 363(9417):1283-5. DOI: 10.1016/S0140-6736(04)16002-9. View

Craig S, Anderson L, Schache A, Moran M, Graham L, Currie K . Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach. Br J Cancer. 2019; 120(8):827-833. PMC: 6474272. DOI: 10.1038/s41416-019-0414-9. View

Kleter B, van Doorn L, Schrauwen L, Molijn A, Sastrowijoto S, Ter Schegget J . Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999; 37(8):2508-17. PMC: 85270. DOI: 10.1128/JCM.37.8.2508-2517.1999. View

Yegnasubramanian S, Kowalski J, Gonzalgo M, Zahurak M, Piantadosi S, Walsh P . Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004; 64(6):1975-86. DOI: 10.1158/0008-5472.can-03-3972. View

Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K . Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res. 2005; 11(3):1219-25. View

10.

Dietrich D, Hasinger O, Liebenberg V, Field J, Kristiansen G, Soltermann A . DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagn Mol Pathol. 2012; 21(2):93-104. DOI: 10.1097/PDM.0b013e318240503b. View

11.

Kreimer A, Villa A, Nyitray A, Abrahamsen M, Papenfuss M, Smith D . The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev. 2010; 20(1):172-82. PMC: 3027138. DOI: 10.1158/1055-9965.EPI-10-0682. View

12.

Wang Q, Gao P, Wang X, Duan Y . The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci Rep. 2014; 4:6802. PMC: 4213796. DOI: 10.1038/srep06802. View

13.

Gillison M, Trotti A, Harris J, Eisbruch A, Harari P, Adelstein D . Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2018; 393(10166):40-50. PMC: 6541928. DOI: 10.1016/S0140-6736(18)32779-X. View

14.

Giuliano A, Nedjai B, Lorincz A, Schell M, Rahman S, Banwait R . Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics. Int J Cancer. 2019; 146(4):1018-1030. PMC: 7787351. DOI: 10.1002/ijc.32570. View

15.

Yom S, Torres-Saavedra P, Caudell J, Waldron J, Gillison M, Xia P . Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002). J Clin Oncol. 2021; 39(9):956-965. PMC: 8078254. DOI: 10.1200/JCO.20.03128. View

16.

Marur S, DSouza G, Westra W, Forastiere A . HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010; 11(8):781-9. PMC: 5242182. DOI: 10.1016/S1470-2045(10)70017-6. View

17.

Dickey B, Nedjai B, Preece M, Schell M, Boulware D, Whiting J . Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer. Cancer Med. 2022; 11(20):3735-3742. PMC: 9582688. DOI: 10.1002/cam4.4757. View

18.

Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12:77. PMC: 3068975. DOI: 10.1186/1471-2105-12-77. View

19.

Khalid M, Ting P, Pai A, Russo J, Bakst R, Chai R . Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review. Laryngoscope. 2018; 129(4):877-882. DOI: 10.1002/lary.27296. View

20.

Frakes J, Naghavi A, Demetriou S, Strom T, Russell J, Kish J . Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer. Cancer. 2015; 122(4):634-41. DOI: 10.1002/cncr.29782. View